BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Petronek MS, Spitz DR, Buettner GR, Allen BG. Linking Cancer Metabolic Dysfunction and Genetic Instability through the Lens of Iron Metabolism. Cancers (Basel) 2019;11:E1077. [PMID: 31366108 DOI: 10.3390/cancers11081077] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 Hitchler MJ, Domann FE. The epigenetic and morphogenetic effects of molecular oxygen and its derived reactive species in development. Free Radic Biol Med 2021;170:70-84. [PMID: 33450377 DOI: 10.1016/j.freeradbiomed.2021.01.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
2 Petronek MS, Stolwijk JM, Murray SD, Steinbach EJ, Zakharia Y, Buettner GR, Spitz DR, Allen BG. Utilization of redox modulating small molecules that selectively act as pro-oxidants in cancer cells to open a therapeutic window for improving cancer therapy. Redox Biol 2021;42:101864. [PMID: 33485837 DOI: 10.1016/j.redox.2021.101864] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Kolosnjaj-Tabi J, Kralj S, Griseti E, Nemec S, Wilhelm C, Plan Sangnier A, Bellard E, Fourquaux I, Golzio M, Rols MP. Magnetic Silica-Coated Iron Oxide Nanochains as Photothermal Agents, Disrupting the Extracellular Matrix, and Eradicating Cancer Cells. Cancers (Basel) 2019;11:E2040. [PMID: 31861146 DOI: 10.3390/cancers11122040] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
4 Cheng X, Zhou YC, Zhou B, Huang YC, Wang GZ, Zhou GB. Systematic analysis of concentrations of 52 elements in tumor and counterpart normal tissues of patients with non-small cell lung cancer. Cancer Med 2019;8:7720-7. [PMID: 31643147 DOI: 10.1002/cam4.2629] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Mehdi Z, Petronek MS, Stolwijk JM, Mapuskar KA, Kalen AL, Buettner GR, Cullen JJ, Spitz DR, Buatti JM, Allen BG. Utilization of Pharmacological Ascorbate to Enhance Hydrogen Peroxide-Mediated Radiosensitivity in Cancer Therapy. Int J Mol Sci 2021;22:10880. [PMID: 34639220 DOI: 10.3390/ijms221910880] [Reference Citation Analysis]
6 Ye J, Wang Z, Chen X, Jiang X, Dong Z, Hu S, Li W, Liu Y, Liao B, Han W, Shen J, Xiao M. YTHDF1-enhanced iron metabolism depends on TFRC m6A methylation. Theranostics 2020;10:12072-89. [PMID: 33204330 DOI: 10.7150/thno.51231] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
7 Cushing CM, Petronek MS, Bodeker KL, Vollstedt S, Brown HA, Opat E, Hollenbeck NJ, Shanks T, Berg DJ, Smith BJ, Smith MC, Monga V, Furqan M, Howard MA, Greenlee JD, Mapuskar KA, St-Aubin J, Flynn RT, Cullen JJ, Buettner GR, Spitz DR, Buatti JM, Allen BG, Magnotta VA. Magnetic resonance imaging (MRI) of pharmacological ascorbate-induced iron redox state as a biomarker in subjects undergoing radio-chemotherapy. Redox Biol 2021;38:101804. [PMID: 33260088 DOI: 10.1016/j.redox.2020.101804] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
8 Lyssiotis CA, Nagrath D. Metabolic Reprogramming and Vulnerabilities in Cancer. Cancers (Basel) 2019;12:E90. [PMID: 31905922 DOI: 10.3390/cancers12010090] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
9 Petronek MS, Spitz DR, Allen BG. Iron-Sulfur Cluster Biogenesis as a Critical Target in Cancer. Antioxidants (Basel) 2021;10:1458. [PMID: 34573089 DOI: 10.3390/antiox10091458] [Reference Citation Analysis]
10 Zhang ZJ, Wang KP, Mo JG, Xiong L, Wen Y. Photodynamic therapy regulates fate of cancer stem cells through reactive oxygen species. World J Stem Cells 2020; 12(7): 562-584 [PMID: 32843914 DOI: 10.4252/wjsc.v12.i7.562] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
11 Zhou M, Xie Y, Xu S, Xin J, Wang J, Han T, Ting R, Zhang J, An F. Hypoxia-activated nanomedicines for effective cancer therapy. Eur J Med Chem 2020;195:112274. [PMID: 32259703 DOI: 10.1016/j.ejmech.2020.112274] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
12 Karmi O, Sohn YS, Marjault HB, Israeli T, Leibowitz G, Ioannidis K, Nahmias Y, Mittler R, Cabantchik IZ, Nechushtai R. A Combined Drug Treatment That Reduces Mitochondrial Iron and Reactive Oxygen Levels Recovers Insulin Secretion in NAF-1-Deficient Pancreatic Cells. Antioxidants (Basel) 2021;10:1160. [PMID: 34439408 DOI: 10.3390/antiox10081160] [Reference Citation Analysis]
13 Orel VE, Dasyukevich O, Rykhalskyi O, Orel VB, Burlaka A, Virko S. Magneto-mechanical effects of magnetite nanoparticles on Walker-256 carcinosarcoma heterogeneity, redox state and growth modulated by an inhomogeneous stationary magnetic field. Journal of Magnetism and Magnetic Materials 2021;538:168314. [DOI: 10.1016/j.jmmm.2021.168314] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Li L, Han Y, Zheng Z, Wang C, Nie K, Li J, Zhang R, Ru J, Ma C. A luminescent Zn-MOF constructed from l-aspartic acid and 4,4-bipyridine: Selectively and sensitively detect Fe3+ and 2,4,6-trinitrophenol (TNP) in aqueous solution. Journal of Solid State Chemistry 2021;295:121887. [DOI: 10.1016/j.jssc.2020.121887] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
15 Kery M, Papandreou I. Emerging strategies to target cancer metabolism and improve radiation therapy outcomes. Br J Radiol 2020;93:20200067. [PMID: 32462882 DOI: 10.1259/bjr.20200067] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
16 Serra M, Columbano A, Ammarah U, Mazzone M, Menga A. Understanding Metal Dynamics Between Cancer Cells and Macrophages: Competition or Synergism? Front Oncol 2020;10:646. [PMID: 32426284 DOI: 10.3389/fonc.2020.00646] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Abramenko N, Kejík Z, Kaplánek R, Tatar A, Brogyányi T, Pajková M, Sýkora D, Veselá K, Antonyová V, Dytrych P, Ikeda-Saito M, Martásek P, Jakubek M. Spectroscopic study of in situ-formed metallocomplexes of proton pump inhibitors in water. Chem Biol Drug Des 2021;97:305-14. [PMID: 32854159 DOI: 10.1111/cbdd.13782] [Reference Citation Analysis]
18 Guo Q, Li L, Hou S, Yuan Z, Li C, Zhang W, Zheng L, Li X. The Role of Iron in Cancer Progression. Front Oncol 2021;11:778492. [PMID: 34858857 DOI: 10.3389/fonc.2021.778492] [Reference Citation Analysis]
19 Jing FY, Zhou LM, Ning YJ, Wang XJ, Zhu YM. The Biological Function, Mechanism, and Clinical Significance of m6A RNA Modifications in Head and Neck Carcinoma: A Systematic Review. Front Cell Dev Biol 2021;9:683254. [PMID: 34136491 DOI: 10.3389/fcell.2021.683254] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Yu X, Dong W, Han H, Zhao J, Li D. A water-stable Zn (II) coordination polymer as fluorescent sensor for selective and sensitive detection of antibiotics and Fe3+. Journal of Solid State Chemistry 2021;296:122032. [DOI: 10.1016/j.jssc.2021.122032] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
21 Ibrahim O, O'Sullivan J. Iron chelators in cancer therapy. Biometals 2020;33:201-15. [PMID: 32757166 DOI: 10.1007/s10534-020-00243-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]